News

Takeda and Pronova BioPharma have announced that the advancement of TAK-085 (omega-3 acid ethyl esters 90) for the treatment of hypertriglyceridemia into Phase 3 clinical programs in Japan.

Evotec has received a milestone payment from Ono Pharmaceutical (Ono) from its research collaboration aimed at identifying inhibitors for a protease target. The milestone is received for the

Ipsen reports the preliminary results of a Phase I trial in metastatic breast cancer with BN83495, first-in-class orally available irreversible steroid sulfatase (STS) inhibitor. In the course of

Basilea Pharmaceutica has announced that Toctino (alitretinoin) was recommended for regulatory approval under the repeat-use procedure in 13 additional EU Member States as well as in Norway and

Abbott has entered into a definitive agreement to acquire Starlims Technologies for approximately $123m in cash. As Abbott integrates Starlims into its existing portfolio of laboratory information management

FDA has granted Emergency Use Authorization (EUA) for DxNA’s 2009 H1N1 influenza virus diagnostic test for use in its GeneSTAT detection platform. The new platform enables fast detection

Bioo Scientific has launched T3 Conjugation Kit which allows scientists to deliver siRNA into targeted cell types. The company’s patent pending Kit can also be used for targeted

Clarient and BioView have reported that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung

Elan Drug Technologies, a business unit of Elan, receives approval from the Japanese Ministry of Health, Labour and Welfare for Emend (aprepitant) for the treatment of cancer chemotherapy-induced